Search Results 211-220 of 38842 for Two-phase

  1. Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    The purpose of this study is to determine the optimal biologic dose (OBD) and recommended Phase 2 dose (RP2D) of BMF-219 monotherapy (Cohorts 1, 2, 3, and 4).

  2. A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens - Mayo Clinic

    This is a Phase 2, open-label, single arm study to evaluate the safety and efficacy of niraparib in ovarian cancer patients who have received three or four ...

  3. VE303 for Prevention of Recurrent Clostridioides Difficile Infection (RESTORATiVE303) - Mayo Clinic

    The objectives and endpoints are identical for Stage 1 (recurrent CDI) and Stage 2 (high-risk primary CDI). Only adults will be enrolled at Mayo Clinic Arizona ...

  4. Myelofibrosis Clinical Trials - Mayo Clinic Research

    The Stage 2 portion will enroll up to 18 patients with each of the 4 myeloproliferative malignancies: SM, PED, MF, and CMML. ... A Phase 2, Multi-center, Open- ...

  5. VE303 for Prevention of Recurrent Clostridioides Difficile Infection - Mayo Clinic

    The objectives and endpoints are identical for Stage 1 (recurrent CDI) and Stage 2 (high-risk primary CDI). Participation eligibility. Participant eligibility ...

  6. Pre-Clerkship - Curriculum - M.D. Program - Mayo Clinic Alix School of Medicine

    ... Phase, which focuses on establishing foundational medical knowledge. ... Dedicated study time is provided during the final six months of year two to prepare for ...

  7. Auranofin and Sirolimus in Treating Participants With Ovarian Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Chronic kidney disease - Diagnosis and treatment - Mayo Clinic

    Certain blood pressure medicines. Taking an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin 2 receptor blocker (ARB) has been shown to protect ...

  9. YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...

  10. Liposarcoma Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well alisertib ... The main purpose of this study is to evaluate the safety and efficacy of two ... The present study is an open- ...